The effect of oxygen free radical scavengers on the recovery of regional myocardial function after acute coronary occlusion and surgical reperfusion. 1988

F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
Department of Surgery, Harvard Medical School, Boston, Mass.

This study investigated the effects of the oxygen free radical scavengers superoxide dismutase and catalase, the peroxide ion inhibitor, in crystalloid potassium cardioplegic solution on infarct size and global and regional myocardial function after occlusion of the left anterior descending artery and surgical reperfusion in young sheep on cardiopulmonary bypass. After 1 hour of occlusion, the animals were randomized to receive either routine potassium cardioplegia or cardioplegia with superoxide dismutase and catalase. Global hemodynamics measured by maximum rate of pressure rise showed significant improvement after 5 hours of reperfusion in the group treated with superoxide dismutase and catalase (1843 +/- 163 versus 979 +/- 191, p less than 0.001). Regional myocardial function was measured by ultrasonic crystals implanted in the ischemic area and in a nonischemic control segment. The percent systolic shortening or bulging was calculated. At end of reperfusion in the animals treated with superoxide dismutase and catalase, there was active shortening in the ischemic area after reperfusion of +9.2% +/- 0.4% versus 2.1% +/- 0.8% in untreated animals (p less than 0.001). Infarct size measured by triphenyltetrazolium chloride staining showed significant difference (p less than 0.001) between animals treated with superoxide dismutase and catalase (0.9% +/- 0.1%) and control animals (61% +/- 70%). Superoxide dismutase and catalase given in the cardioplegic solution before reperfusion of an acutely ischemic area of myocardium enhances recovery of contractile function and results in a significant reduction in infarct size, which suggests improved salvage of the ischemic myocardium.

UI MeSH Term Description Entries
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females

Related Publications

F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
October 1985, Circulation,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
February 1996, American heart journal,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
November 1989, The Journal of cardiovascular nursing,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
January 1974, The American journal of cardiology,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
December 1998, Pharmacological research,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
December 1984, Giornale italiano di cardiologia,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
January 1986, British journal of pharmacology,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
March 1994, Circulation,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
September 1982, The Journal of thoracic and cardiovascular surgery,
F Gharagozloo, and F J Melendez, and R A Hein, and R E Austin, and R J Shemin, and V J DiSesa, and L H Cohn
January 1982, Arzneimittel-Forschung,
Copied contents to your clipboard!